Tracking thinking skills and brain scans in people getting radiation for brain tumors
Follows adults with brain tumors having radiation, checking thinking tests and brain scans.
Key facts
- Who runs it
- Jona Hattangadi-Gluth
- Where
- San Diego, United StatesSee the site
- Trial code
- Registry title
- Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- Jan 2015
- Expected to end
- Dec 2030
- Type of study
- Observational
- Record updated
- 10 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a primary brain tumor who will have radiation therapy to part of the brain, given in several sessions. It studies thinking and memory changes and brain scans over time.
- Age
- 18 Years to 99 Years
- Sex
- All
- Disease stage
- Primary brain tumor (a tumor that started in the brain), such as glioma, meningioma or schwannoma. Karnofsky performance status (KPS) ≥70, a measure of how well you manage daily life. Life expectancy of ≥1 year.
- Earlier treatment
- People who had radiation therapy to the brain before cannot join. People must be planned to receive fractionated partial brain radiation therapy.
Main reasons for not taking part
- Not able to have an MRI scan with contrast dye
- Earlier radiation therapy to the brain
- Not able to complete thinking and memory tests
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patients 18 years or older
- Karnofsky performance status (KPS) ≥70
- Life expectancy of ≥1 year
- Primary brain tumor patients who will receive fractionated partial brain RT
- Able to complete neurocognitive assessments
Who cannot take part
- Prior brain RT
- Inability to undergo MRI with contrast
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Where in United States
- Moores Cancer CenterSan Diego, United StatesContact: Lara J RoseTaking people
About the trial
What the trial wants to find out
In this proposal, the investigators introduce a novel, translational study to prospectively examine primary brain tumor patients undergoing fractionated radiation therapy to the brain. Quantitative neuroimaging, radiation dose information, and directed neurocognitive testing will be acquired through this study to improve understanding of cognitive changes associated with radiation dosage to non-targeted tissue, and will provide the basis for evidence-based cognitive- sparing brain radiotherapy.
The group in the trial
- Primary brain tumour patients receiving RT
Primary brain tumor patients are screened at time of consultation for this observational study, and the study population is diverse across sex/gender, and racial/ethnic groups.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Longitudinal Prospective Study of Neurocognitive Outcomes and Multimodal Quantitative Neuroimaging Outcomes in Primary Brain Tumor Patients Receiving Brain Radiotherapy
- Plain-language title
- Tracking thinking skills and brain scans in people getting radiation for brain tumorsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05576103, who can take part
- Record updated
- 10 June 2026